Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata is a common autoimmune condition causing varying hair loss, diagnosed by specific patterns of inflammation around hair follicles, with several treatment options available.

There is no link between hair loss and prostate enlargement.

Hormonal treatments are effective for severe or persistent acne and should be used with other acne therapies, considering potential side effects.

Biologic agents are effective for severe hidradenitis suppurativa when other treatments fail.

Severe COVID-19 may cause hair loss, and doctors recommend supplements and topical treatments to manage it.

Autoimmune diseases can cause hair loss, and early treatment is important to prevent permanent damage.

Men are more likely to have severe respiratory viral infections like COVID-19 due to hormonal and genetic differences, while women generally have stronger immune responses.

Baricitinib effectively regrows scalp hair in most people with severe alopecia areata.

Hormonal therapy is a good option for women with severe acne, especially when there's a chance of hormone imbalance.

Patients with myotonic dystrophy often have skin problems that suggest early aging and vitamin D issues, and the severity of these problems is linked to their genetic condition and vitamin D levels.

Hormone imbalances from endocrine diseases can cause various skin conditions that help diagnose and treat these diseases early.

Thorough evaluation and surgery are crucial for managing rare ovarian tumors in postmenopausal women with high androgen levels.

D-OCT shows increased blood vessel growth in response to tissue damage in Frontal Fibrosing Alopecia and is useful for diagnosis and monitoring.

FFA has higher long-term remission rates than LPP.

Tofacitinib improved hair regrowth and quality of life in children with alopecia areata, with mild side effects.

Diagnosing and managing PCOS in teens is hard, but early diagnosis and lifestyle changes are key, and more research is needed for long-term health.

Half of people with Alopecia Areata may see hair regrowth within a year without treatment, but recovery is unpredictable.

A new type of sudden, complete female hair loss was found, with most patients fully recovering within 6 months without needing steroid treatment.

Phototrichogram and hair diameter measurements are effective, noninvasive ways to assess hair growth and detect early hair loss, with the most common pattern being reduced hair density.

Women with PCOS are at high risk of glucose metabolism issues and heart diseases, especially if overweight, highlighting the need for early intervention.

The document concludes that treatments for cicatricial alopecia are not well-supported by evidence, but hair transplantation shows more predictable and satisfactory results.

A 3-year-old girl with skin mast cell buildup and congenital baldness improved with treatment, suggesting a rare link between these conditions.

CCCA is a scarring hair loss condition mainly in African descent women, possibly caused by genetics and hairstyling, treated with gentle hair care and medications.

Some psychiatric drugs can cause severe hair loss, especially valproic acid, and it's more likely in women or those with thyroid issues or past hair loss.

Dermoscopy shows that diffuse alopecia areata progresses through specific hair growth stages.

Alopecia areata in young Ukrainian men varies in severity, requiring personalized treatment.

The document suggests a possible link between mast cells and scarring alopecia, recommending more research for potential treatments.

Alopecia Areata is a complex, unpredictable autoimmune hair loss condition with limited treatment options and a significant psychological impact.

Hidradenitis suppurativa, a chronic skin disease, can be managed with antibiotics, lifestyle changes, and in severe cases, surgery. Early diagnosis and careful planning are key, and laser treatment can be an efficient solution for mild to severe cases.